#PortalHypertension Archives

Voice of China | Professor Jidong Jia and Professor Hong You’s Team: Carvedilol Combined with Antiviral Treatment Can Delay the Progression of Moderat

By Mourabit Halima 2024.01.17

Editor's Note: Portal hypertension is the main pathophysiological cause of decompensation events in patients with cirrhosis and is a major driver of liver function deterioration. Non-selective β-blockers (NSBBs) are widely…